Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Cost minimization of on-demand maintenance therapy with proton pump inhibitors in nonerosive gastroesophageal reflux disease.

Hughes DA, Marchetti M, Colombo G.

Expert Rev Pharmacoecon Outcomes Res. 2005 Feb;5(1):29-38. doi: 10.1586/14737167.5.1.29.

PMID:
19807558
2.

Diagnosis and management of non-erosive reflux disease--the Vevey NERD Consensus Group.

Modlin IM, Hunt RH, Malfertheiner P, Moayyedi P, Quigley EM, Tytgat GN, Tack J, Heading RC, Holtman G, Moss SF; Vevey NERD Consensus Group.

Digestion. 2009;80(2):74-88. doi: 10.1159/000219365. Epub 2009 Jun 17.

3.

The nonerosive reflux disease-gastroesophageal reflux disease controversy.

Winter JW, Heading RC.

Curr Opin Gastroenterol. 2008 Jul;24(4):509-15. doi: 10.1097/MOG.0b013e3283025c57. Review.

PMID:
18622168
4.

Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.

Martínek J, Benes M, Hucl T, Drastich P, Stirand P, Spicák J.

Scand J Gastroenterol. 2008;43(7):794-800. doi: 10.1080/00365520801908928.

PMID:
18584517
5.

A review of rabeprazole in the treatment of acid-related diseases.

Pace F, Pallotta S, Casalini S, Porro GB.

Ther Clin Risk Manag. 2007 Jun;3(3):363-79.

6.

On-demand therapy for gastroesophageal reflux disease.

Metz DC, Inadomi JM, Howden CW, van Zanten SJ, Bytzer P.

Am J Gastroenterol. 2007 Mar;102(3):642-53. Review.

PMID:
17156134
7.

Time trends of gastroesophageal reflux disease: a systematic review.

El-Serag HB.

Clin Gastroenterol Hepatol. 2007 Jan;5(1):17-26. Epub 2006 Dec 4. Review.

PMID:
17142109
8.
9.

The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.

Shapiro M, Green C, Faybush EM, Esquivel RF, Fass R.

Aliment Pharmacol Ther. 2006 Jan 15;23(2):321-9.

10.

Treatment of gastroesophageal reflux disease.

Pettit M.

Pharm World Sci. 2005 Dec;27(6):432-5. Review.

PMID:
16341949
11.

Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese.

Mishima I, Adachi K, Arima N, Amano K, Takashima T, Moritani M, Furuta K, Kinoshita Y.

Scand J Gastroenterol. 2005 Sep;40(9):1005-9.

PMID:
16211699
12.

High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report.

Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L, Talley NJ, Agréus L.

Scand J Gastroenterol. 2005 Mar;40(3):275-85.

PMID:
15932168
13.
14.

Effectiveness of proton pump inhibitors in nonerosive reflux disease.

Dean BB, Gano AD Jr, Knight K, Ofman JJ, Fass R.

Clin Gastroenterol Hepatol. 2004 Aug;2(8):656-64. Review.

PMID:
15290657
15.

Six-month trial of on-demand rabeprazole 10 mg maintains symptom relief in patients with non-erosive reflux disease.

Bytzer P, Blum A, De Herdt D, Dubois D; Trial Investigators.

Aliment Pharmacol Ther. 2004 Jul 15;20(2):181-8.

16.

Comparison of the effect on intragastric pH of a single dose of omeprazole or rabeprazole: which is suitable for on-demand therapy?

Inamori M, Togawa J, Takahashi K, Yoneda M, Fujisawa N, Iwasaki T, Ozawa Y, Kikuchi T, Muramatsu K, Chiguchi G, Matsumoto S, Kawamura H, Abe Y, Kirikoshi H, Kobayashi N, Sakaguchi T, Takamura T, Nakajima A, Ueno N, Sekihara H.

J Gastroenterol Hepatol. 2003 Sep;18(9):1034-8.

PMID:
12911659
17.

Non-erosive reflux disease (NERD)--acid reflux and symptom patterns.

Martinez SD, Malagon IB, Garewal HS, Cui H, Fass R.

Aliment Pharmacol Ther. 2003 Feb 15;17(4):537-45.

18.

Esomeprazole 40 mg and 20 mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6 months.

Talley NJ, Venables TL, Green JR, Armstrong D, O'Kane KP, Giaffer M, Bardhan KD, Carlsson RG, Chen S, Hasselgren GS.

Eur J Gastroenterol Hepatol. 2002 Aug;14(8):857-63.

PMID:
12172406
19.

Rabeprazole in nonerosive gastroesophageal reflux disease: a randomized placebo-controlled trial.

Miner P Jr, Orr W, Filippone J, Jokubaitis L, Sloan S.

Am J Gastroenterol. 2002 Jun;97(6):1332-9.

PMID:
12094846
20.

Supplemental Content

Support Center